New Zealand markets closed

LLY Jul 2024 730.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
86.800.00 (0.00%)
As of 03:38PM EST. Market open.
Full screen
Previous close86.80
Open82.15
Bid0.00
Ask0.00
Strike730.00
Expiry date2024-07-19
Day's range82.15 - 89.00
Contract rangeN/A
Volume13
Open interest142
  • Insider Monkey

    20 Fastest Growing Biotech Companies in the US

    In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]

  • Zacks

    Zacks Market Edge Highlights: AAPL, COST, WSM, LLY and HLT

    AAPL, COST, WSM, LLY and HLT have been highlighted in this Market Edge article.

  • Reuters

    Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

    The widespread use of powerful new weight-loss drugs in the United States could boost gross domestic product by 1% in the coming years as lower obesity-related complications are likely to boost workplace efficiency, according to Goldman Sachs. Some analysts have predicted the market for weight-loss drugs could reach $100 billion a year by the end of the decade, with Ozempic maker Novo Nordisk and Mounjaro producer Eli Lilly leading the race. The use of GLP-1s could increase by anywhere between 10 to 70 million consumers by 2028, Goldman Sachs said on Thursday.